Presidential Lecture

in Japanese

in English

Invited Lecture1
Medical treatment of Pulmonary Hypertension

Moderator	Aiko Ogawa	(National Hospital Organization Okayama Medical Center)
Speaker	Marion Delcroix	(University of Leuven (KUL) and Kortrijk (KULAK), Belgium)

in English

Invited Lecture2
Developments in Pulmonary Hypertension

Moderator	Hiroaki Shimokawa	(Tohoku University School of Medicine)
Speaker	Harm Jan Bogaard	(Amsterdam University Medical Centers, Netherlands)

in English

Invited Lecture3
The past, present and future of PTE/PEA for CTEPH

Moderator	Hitoshi Ogino	(Tokyo Medical University)
Speaker	Stuart Jamieson	(University of California, San Diego, USA)

in English

Invited Lecture4
Medical Therapy in CTEPH –state of the art

Moderator	Takeshi Ogo	(National Cerebral and Cardiovascular Center Hospital)
Speaker	Joanna Pepke-Zaba	(Royal Papworth Hospital, UK)

in English

Invited Lecture5
Diagnostic and therapeutic challenges of PAH with comorbidities

Moderator	Keiichi Fukuda	(Keio University School of Medicine)
Speaker	Michele D’Alto	(Monaldi Hospital, University "L. Vanvitelli", Italy)

in English

Invited Lecture6
Genotype Phenotype Relationships in Pulmonary Hypertension

Moderator	Yuichi Tamura	(International University of Health and Werfare Mita Hospital)
Speaker	Marc Humbert	(Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France)

Presidential Special
Program

in Japanese

International CTEPH
Symposium

in English

State-of-the-art CTEPH treatment in the world

Moderator	Hiromi Matsubara	(Okayama Medical Center, Japan)*
	Hitoshi Ogino	(Tokyo Medical University, Japan)
Speaker	* Executive Board of the ICA
	Keynote：Current treatment algorism for CTEPH: PEA, BPA, Medical treatment, and Hybrid
	Gerald Simonneau	(Paris-Sud University, France)*
	CTEPH Treatment: Belgium (or Leuven) experience
	Marion Delcroix	(University Hospitals (UZ) Leuven, Belgium)*
	CTEPH Treatment: UK (or Papwprth) experience
	Joanna Pepke-Zaba	(Royal Papworth Hospital, UK)*
	CTEPH treatment: German (or Kerckhof-Klinik) experience
	Eckhard Mayer	(Kerckhoff-Klinik GmbH, Germany)*
	CTEPH treatment: San Diego experience
	Stuart Jamieson	(University of California, San Diego, USA)*
	CTEPH treatment: Japanese (or NCVC) experience
	Takeshi Ogo	(National Cerebral and Cardiovascular Center, Japan)
	Panel Discussion
	Elie Fadel	(Paris-Sud University, France)

Late-Breaking Session

in Japanese

in Japanese

Symposium1

in English

Symposium2
Strategies for treatment of CTEPH from the view point of pathogenesis

Moderator	Kotaro Abe	(Kyushu University Hospital)
	Nobuhiro Tanabe	(Chibaken Saiseikai Narashino Hospital)
Speaker	The Role of Imaging in Diagnosis and Treatment of CTEPH
	Masashi Tamura	(Keio University School of Medicine)
	The thrombus organization process of CTEPH in representative European and Japanese patients
	Seiichiro Sakao	(Chiba University)
	Novel Animal Model of CTEPH with Thrombin-Activatable Fibrinolysis Inhibitor Overexpressing Mice
	Nobuhiro Yaoita	(Tohoku University Hospital)
	Pathophysiology and treatment strategy from the viewpoint of CTEPH surgery
	Shun Suzuki	(Tokyo Medical University)
	The pathology of chronic thromboembolic pulmonary hypertension
	Hatsue Ueda	(National Cerebral and Cardiovascular Center Hospital)
	Combined/hybrid CTEPH therapies based on medical treatment
	Marion Delcroix	(University of Leuven (KUL) and Kortrijk (KULAK), Belgium)

in Japanese

Symposium3

in Japanese

Symposium4

in English

Panel Discussion1
Current situations of BPA and PEA in Japan

Moderator	Jun Yamashita	(Tokyo Medical University)
	Kenji Minatoya	(Kyoto University Graduate School of Medicine)
Speaker	Short Comment
	Stuart Jamieson	(University of California, San Diego, USA)
	PEA using the Pavia technique
	Keiichi Ishida	(Chiba University)
	Possibilities and limitations of BPA to achieve WHO-FC I
	Nobutaka Ikeda	(Toho University Ohashi Medical Center)
	Usefulness of Peripheral pressure directed BPA for CTEPH
	Shinsuke Takeuchi	(Kyorin University)
	Preceding BPA before PEA
	Shun Suzuki	(Tokyo Medical University)
	Collaboration with BPA and PEA for Chronic Thromboembolic Pulmonary Hypertension
	Yu Taniguchi	(Kobe University Graduate School of Medicine)

in Japanese

Panel Discussion2

in Japanese

Panel Discussion3

in Japanese

Panel Discussion4

in Japanese

Panel Discussion5

in Japanese

Educational Lecture1

in Japanese

Educational Lecture2

in Japanese

Educational Lecture3

in Japanese

Educational Lecture4

in Japanese

Educational Lecture5

in Japanese

Educational Lecture6

in Japanese

Educational Lecture7

in Japanese

Pro/Con1

in Japanese

Pro/Con2

in Japanese

Pro/Con3

in Japanese

Pro/Con4

Case Study

in Japanese

Young Investigator's
Award
(Basic Session, Clinical Session)

in Japanese

JPCPHS Society
Encouragement Award Lecture

in Japanese

JPCPHS Society Highest
Award Lecture Honoring
Dr. Shigeo Yamaki, a distinguished Scientist in pulmonary hypertension field

in Japanese

in English

Luncheon Seminar1
Latest Topics of Treatment for CTEPH Including the Importance and Clinical Meaning oh Riociguat

Bayer Yakuhin, Ltd

Moderator	Hiromi Matsubara	(National Hospital Organization Okayama Medical Center)
Speaker	Latest Topics of Treatment for CTEPH Including the Importance and Clinical Meaning oh Riociguat
	Marion Delcroix	(University of Leuven (KUL) and Kortrijk (KULAK), Belgium)

in Japanese

Luncheon Seminar2

in Japanese

Luncheon Seminar3

in English

Luncheon Seminar4
Initial combination therapy and long-term outcomes in pulmonary arterial hypertension

Janssen Pharmaceutical K.K. / Nippon Shinyaku Co., Ltd.

Moderator	Hiromi Matsubara	(National Hospital Organization Okayama Medical Center)
Speaker	Initial combination therapy and long-term outcomes in pulmonary arterial hypertension
	Marc Humbert	(Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France)

in English

Luncheon Seminar5
Treatment Options and Strategy for PAH

Bayer Yakuhin, Ltd

Moderator	Takahisa Kondo	(Nagoya University Graduate School of Medicine)
Speaker	Treatment Options and Strategy for PAH
	Joanna Pepke-Zaba	(Royal Papworth Hospital, UK)

in Japanese

Luncheon Seminar6

in Japanese

Luncheon Seminar7

in English

Morning Seminar1
Evaluation of right ventricular function in PAH

Nippon Shinyaku Co., Ltd.

Moderator	Aiko Ogawa	(National Hospital Organization Okayama Medical Center)
Speaker	Evaluation of right ventricular function in PAH
	Anton Vonk Noordegraaf	(Amsterdam University Medical Centers, Netherlands)

in Japanese

Morning Seminar2

in Japanese

Evening Seminar1

in Japanese

Evening Seminar2

in Japanese

Evening Seminar3